Vimarsana
Biggest News Aggregation in the World

Page 8 - Michael Castagna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Castagna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Castagna Today - Breaking & Trending Today

Why MannKind Stock Soared 19% Higher on Tuesday - Vimarsana News

Why MannKind Stock Soared 19% Higher on Tuesday

The biotech delivered quite an impressive earnings report.

Source: fool.com
Related Topics:
Michael Castagna
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference - Vimarsana News

MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices

MannKind (MNKD) to Release Earnings on Monday - Vimarsana News

MannKind (MNKD) to Release Earnings on Monday

MannKind (NASDAQ:MNKD – Get Free Report) is scheduled to announce its earnings results after the market closes on Monday, August 7th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. MannKind (NASDAQ:MNKD – Get […]

MannKind Co. (NASDAQ:MNKD) Shares Bought by Hunter Associates Investment Management LLC - Vimarsana News

MannKind Co. (NASDAQ:MNKD) Shares Bought by Hunter Associates Investment Management LLC

Hunter Associates Investment Management LLC grew its position in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 31.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,570 shares of the biopharmaceutical company’s stock after buying an additional 12,000 shares during the quarter. […]

Cantor Fitzgerald Comments on MannKind Co.'s FY2024 Earnings (NASDAQ:MNKD) - Vimarsana News

Cantor Fitzgerald Comments on MannKind Co.'s FY2024 Earnings (NASDAQ:MNKD)

MannKind Co. (NASDAQ:MNKD – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for MannKind in a report released on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer anticipates that the biopharmaceutical company will earn $0.09 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]